文献速递胸部肿瘤

肺癌筛查中新发亚实性结节的NELSON试验解读

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.
PubMed 文献 · J Thorac Oncol · 2018-07-12

在NELSON低剂量CT肺癌筛查试验中,基线筛查后新发亚实性结节见于0.7%的参与者,仅6%的新发亚实性结节参与者最终诊断为(前)恶性病变,且均为原位腺癌、分期为I期,67%的亚实性结节在后续随访中消退。提示与新生实性结节不同,新发亚实性结节或无需更积极的随访策略。

要点

  • 新发亚实性结节见于0.7%的筛查参与者,远低于新生实性结节。
  • 仅6%的新发亚实性结节参与者诊断为(前)恶性,均为I期原位腺癌。
  • 67%的亚实性结节在后续随访中消退,支持保守随访策略。

核心结论

  • 基线筛查后新发亚实性结节的发生率低于1%,且恶性概率低、分期早,可能不需要比新生实性结节更积极的随访。

主要发现

  • 三轮发病率筛查中,51名参与者检出60个新发亚实性结节(43个部分实性,17个非实性),占至少一次发病率筛查参与者的0.7%(51/7295)。
  • 6%(3/51)的新发亚实性结节参与者最终诊断为该结节相关的(前)恶性病变,均为(原位)腺癌,诊断性检查(首次发现后转诊时间分别为950天、364天和366天)显示分期良好(I期)。
  • 在49个有额外随访筛查的亚实性结节中,67%(33/49)正在消退。

临床怎么用

  • 对于基线筛查后新发的亚实性结节,可考虑较新生实性结节更保守的随访策略,避免过度干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Low-dose computed tomography (LDCT) lung cancer screening is recommended in the United States. While new solid nodules after baseline screening have a high lung cancer probability at small size and require lower size cutoff values than baseline nodules, there only is limited evidence on management of new subsolid nodules. METHODS: Within the Dutch-Belgian randomized controlled LDCT lung cancer screening trial (NELSON), 7557 participants underwent baseline screening between April 2004 and December 2006. Participants with new subsolid nodules detected after the baseline screening round were included. RESULTS: In the three incidence screening rounds, 60 new subsolid nodules (43 [72%] part-solid, 17 [28%] nonsolid) not visible in retrospect were detected in 51 participants, representing 0.7% (51 of 7295) of participants with at least one incidence screening. Eventually, 6% (3 of 51) of participants with a new subsolid nodule were diagnosed with (pre-)malignancy in such a nodule. All (pre-)malignancies were adenocarcinoma (in situ) and diagnostic workup (referral 950, 364, and 366 days after first detection, respectively) showed favorable staging (stage I). Overall, 67% (33 of 49) of subsolid nodules with an additional follow-up screening were resolving. CONCLUSIONS: Less than 1% of participants in LDCT lung cancer screening presents with a new subsolid nodule after baseline. Contrary to new solid nodules, data suggest that new subsolid nodules may not require a more aggressive follow-up.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Walter JE, Heuvelmans MA, Yousaf-Khan U, et al. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial. J Thorac Oncol. 2018. PMID: 29775805. doi:10.1016/j.jtho.2018.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。